AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2012
Nov 21, 2012
33510_dirs_2012-11-21_c4c5de8f-44bc-43e2-9b6d-ff90dee48d88.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2012-11-16
Reporting Person: Babcock Dwight William (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-16 | Common Stock | P | 20000 | $0.425 | Acquired | 226373 | Direct |
| 2012-11-16 | Common Stock | P | 5000 | $0.4199 | Acquired | 231373 | Direct |
| 2012-11-16 | Common Stock | P | 10000 | $0.415 | Acquired | 241373 | Direct |
| 2012-11-16 | Common Stock | P | 100 | $0.37 | Acquired | 241473 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16